EMPIRE STATE REALTY TRUST-A (ESRT) Fundamental Analysis & Valuation

NYSE:ESRTUS2921041065

Current stock price

5.16 USD
+0.04 (+0.78%)
At close:
5.16 USD
0 (0%)
After Hours:

This ESRT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ESRT Profitability Analysis

1.1 Basic Checks

  • ESRT had positive earnings in the past year.
  • ESRT had a positive operating cash flow in the past year.
  • Of the past 5 years ESRT 4 years were profitable.
  • Of the past 5 years ESRT 4 years had a positive operating cash flow.
ESRT Yearly Net Income VS EBIT VS OCF VS FCFESRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • With a Return On Assets value of 0.85%, ESRT perfoms like the industry average, outperforming 52.85% of the companies in the same industry.
  • The Return On Equity of ESRT (3.25%) is comparable to the rest of the industry.
  • ESRT has a Return On Invested Capital (2.87%) which is in line with its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ESRT is in line with the industry average of 3.11%.
  • The 3 year average ROIC (2.75%) for ESRT is below the current ROIC(2.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROIC 2.87%
ROA(3y)1.06%
ROA(5y)0.76%
ROE(3y)3.89%
ROE(5y)2.87%
ROIC(3y)2.75%
ROIC(5y)2.48%
ESRT Yearly ROA, ROE, ROICESRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4

1.3 Margins

  • ESRT has a Profit Margin (4.55%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of ESRT has grown nicely.
  • ESRT's Operating Margin of 18.68% is in line compared to the rest of the industry. ESRT outperforms 43.90% of its industry peers.
  • In the last couple of years the Operating Margin of ESRT has grown nicely.
  • ESRT has a worse Gross Margin (54.04%) than 73.98% of its industry peers.
  • ESRT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
OM growth 3Y0.36%
OM growth 5Y10.63%
PM growth 3Y4.1%
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y-0.01%
ESRT Yearly Profit, Operating, Gross MarginsESRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

4

2. ESRT Health Analysis

2.1 Basic Checks

  • ESRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ESRT has been increased compared to 1 year ago.
  • Compared to 5 years ago, ESRT has less shares outstanding
  • ESRT has a better debt/assets ratio than last year.
ESRT Yearly Shares OutstandingESRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ESRT Yearly Total Debt VS Total AssetsESRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • ESRT has an Altman-Z score of 0.54. This is a bad value and indicates that ESRT is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.54, ESRT is in line with its industry, outperforming 54.47% of the companies in the same industry.
  • ESRT has a Debt/Equity ratio of 1.92. This is a high value indicating a heavy dependency on external financing.
  • ESRT's Debt to Equity ratio of 1.92 is on the low side compared to the rest of the industry. ESRT is outperformed by 69.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Altman-Z 0.54
ROIC/WACC0.49
WACC5.85%
ESRT Yearly LT Debt VS Equity VS FCFESRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • ESRT has a Current Ratio of 2.59. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ESRT (2.59) is better than 93.50% of its industry peers.
  • ESRT has a Quick Ratio of 2.59. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.59, ESRT belongs to the top of the industry, outperforming 93.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.59
ESRT Yearly Current Assets VS Current LiabilitesESRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

4

3. ESRT Growth Analysis

3.1 Past

  • ESRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.10%, which is quite impressive.
  • Measured over the past years, ESRT shows a very strong growth in Earnings Per Share. The EPS has been growing by 57.42% on average per year.
  • ESRT shows a small growth in Revenue. In the last year, the Revenue has grown by 0.05%.
  • The Revenue has been growing slightly by 4.75% on average over the past years.
EPS 1Y (TTM)38.1%
EPS 3Y34.2%
EPS 5Y57.42%
EPS Q2Q%-4.17%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y1.86%
Revenue growth 5Y4.75%
Sales Q2Q%2.96%

3.2 Future

  • Based on estimates for the next years, ESRT will show a very negative growth in Earnings Per Share. The EPS will decrease by -39.35% on average per year.
  • The Revenue is expected to grow by 2.24% on average over the next years.
EPS Next Y-92.97%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
EPS Next 5Y-39.35%
Revenue Next Year2.89%
Revenue Next 2Y2.2%
Revenue Next 3Y1.81%
Revenue Next 5Y2.24%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ESRT Yearly Revenue VS EstimatesESRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ESRT Yearly EPS VS EstimatesESRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6 0.8

4

4. ESRT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 5.93, the valuation of ESRT can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of ESRT indicates a rather cheap valuation: ESRT is cheaper than 96.75% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.73, ESRT is valued rather cheaply.
  • ESRT is valuated quite expensively with a Price/Forward Earnings ratio of 84.31.
  • ESRT's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of ESRT to the average of the S&P500 Index (23.72), we can say ESRT is valued expensively.
Industry RankSector Rank
PE 5.93
Fwd PE 84.31
ESRT Price Earnings VS Forward Price EarningsESRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 93.50% of the companies in the same industry are more expensive than ESRT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.34
ESRT Per share dataESRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • ESRT's earnings are expected to decrease with -61.15% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%

3

5. ESRT Dividend Analysis

5.1 Amount

  • ESRT has a Yearly Dividend Yield of 2.66%. Purely for dividend investing, there may be better candidates out there.
  • In the last 3 months the price of ESRT has falen by -21.58%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • With a Dividend Yield of 2.66, ESRT pays less dividend than the industry average, which is at 7.30. 81.30% of the companies listed in the same industry pay a better dividend than ESRT!
  • ESRT's Dividend Yield is a higher than the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 2.66%

5.2 History

  • The dividend of ESRT decreases each year by -17.38%.
  • ESRT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ESRT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-17.38%
Div Incr Years0
Div Non Decr Years3
ESRT Yearly Dividends per shareESRT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

5.3 Sustainability

  • ESRT pays out 79.65% of its income as dividend. This is not a sustainable payout ratio.
  • The Dividend Rate of ESRT has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP79.65%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
ESRT Yearly Income VS Free CF VS DividendESRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M
ESRT Dividend Payout.ESRT Dividend Payout, showing the Payout Ratio.ESRT Dividend Payout.PayoutRetained Earnings

ESRT Fundamentals: All Metrics, Ratios and Statistics

EMPIRE STATE REALTY TRUST-A

NYSE:ESRT (3/19/2026, 8:04:00 PM)

After market: 5.16 0 (0%)

5.16

+0.04 (+0.78%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-17
Earnings (Next)04-27
Inst Owners103.01%
Inst Owner Change1.34%
Ins Owners0.08%
Ins Owner Change0%
Market Cap878.18M
Revenue(TTM)768.27M
Net Income(TTM)34.89M
Analysts75
Price Target7.51 (45.54%)
Short Float %5.37%
Short Ratio5.47
Dividend
Industry RankSector Rank
Dividend Yield 2.66%
Yearly Dividend0.17
Dividend Growth(5Y)-17.38%
DP79.65%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-13
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.54%
PT rev (3m)-14.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.93
Fwd PE 84.31
P/S 1.15
P/FCF N/A
P/OCF 3.31
P/B 0.82
P/tB 3.2
EV/EBITDA 8.34
EPS(TTM)0.87
EY16.86%
EPS(NY)0.06
Fwd EY1.19%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)1.56
OCFY30.2%
SpS4.5
BVpS6.31
TBVpS1.61
PEG (NY)N/A
PEG (5Y)0.1
Graham Number11.11
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROCE 3.64%
ROIC 2.87%
ROICexc 2.99%
ROICexgc 3.79%
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
FCFM N/A
ROA(3y)1.06%
ROA(5y)0.76%
ROE(3y)3.89%
ROE(5y)2.87%
ROIC(3y)2.75%
ROIC(5y)2.48%
ROICexc(3y)2.96%
ROICexc(5y)2.68%
ROICexgc(3y)3.73%
ROICexgc(5y)3.4%
ROCE(3y)3.48%
ROCE(5y)3.14%
ROICexgc growth 3Y-2.22%
ROICexgc growth 5Y10.35%
ROICexc growth 3Y-1.13%
ROICexc growth 5Y11.75%
OM growth 3Y0.36%
OM growth 5Y10.63%
PM growth 3Y4.1%
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Debt/EBITDA 6.18
Cap/Depr 140.72%
Cap/Sales 34.79%
Interest Coverage 1.49
Cash Conversion 79.7%
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.59
Altman-Z 0.54
F-Score6
WACC5.85%
ROIC/WACC0.49
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.1%
EPS 3Y34.2%
EPS 5Y57.42%
EPS Q2Q%-4.17%
EPS Next Y-92.97%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
EPS Next 5Y-39.35%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y1.86%
Revenue growth 5Y4.75%
Sales Q2Q%2.96%
Revenue Next Year2.89%
Revenue Next 2Y2.2%
Revenue Next 3Y1.81%
Revenue Next 5Y2.24%
EBIT growth 1Y-8.53%
EBIT growth 3Y2.22%
EBIT growth 5Y15.89%
EBIT Next Year144.54%
EBIT Next 3Y36.3%
EBIT Next 5Y22.27%
FCF growth 1Y98.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.21%
OCF growth 3YN/A
OCF growth 5YN/A

EMPIRE STATE REALTY TRUST-A / ESRT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EMPIRE STATE REALTY TRUST-A?

ChartMill assigns a fundamental rating of 4 / 10 to ESRT.


What is the valuation status for ESRT stock?

ChartMill assigns a valuation rating of 4 / 10 to EMPIRE STATE REALTY TRUST-A (ESRT). This can be considered as Fairly Valued.


What is the profitability of ESRT stock?

EMPIRE STATE REALTY TRUST-A (ESRT) has a profitability rating of 5 / 10.


What is the valuation of EMPIRE STATE REALTY TRUST-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EMPIRE STATE REALTY TRUST-A (ESRT) is 5.93 and the Price/Book (PB) ratio is 0.82.


What is the financial health of EMPIRE STATE REALTY TRUST-A (ESRT) stock?

The financial health rating of EMPIRE STATE REALTY TRUST-A (ESRT) is 4 / 10.